2019 SABCS Public Wednesday

Martine Piccart, MD,PhD, discusses Updated APHINITY Trial Data ShowAddition of Pertuzumab to Trastuzumab PlusChemotherapy Continues to Yield Clinical Benefitin Patients WithOperable HER2-positive Early Breast Cancer during Opening Press Conference

San Antonio, TX - SABCS 2019 San Antonio Breast Cancer Symposium - Martine Piccart, MD,PhD, discusses Updated APHINITY Trial Data ShowAddition of Pertuzumab to Trastuzumab PlusChemotherapy Continues to Yield Clinical Benefitin Patients WithOperable HER2-positive Early Breast Cancer during Opening Press Conference here today, Wednesday December 11, 2019. during the San Antonio Breast Cancer Symposium being held at the Henry B. Gonzalez Convention Center in San Antonio, TX. This year is the 42nd Anniversary of the meeting where over 7,500 physicians, researchers, patient advocates and healthcare professionals from over 90 countries attended the meeting which features the latest research on breast cancer treatment and prevention. Photo by © MedMeetingImages/Todd Buchanan 2019 Technical Questions: todd@medmeetingimages.com